These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2126078)

  • 41. Low back pain in Paget's disease of bone.
    Altman RD; Brown M; Gargano F
    Clin Orthop Relat Res; 1987 Apr; (217):152-61. PubMed ID: 2951047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease.
    Wellman HN; Schauwecker D; Robb JA; Khairi MR; Johnston CC
    Clin Orthop Relat Res; 1977; (127):55-62. PubMed ID: 410575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
    Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
    Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photon-deficient bone scan lesion as a precursor of active Paget's disease.
    Jaspers MM; Pauwels EK; Harinck HI; Blom J
    Diagn Imaging Clin Med; 1984; 53(3):144-8. PubMed ID: 6428795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole body retention of Tc-99m phosphate in Paget's disease of bone.
    Hadjipavlou A; Lisbona R; Garbuz D; Abibtbol JJ
    Clin Nucl Med; 1991 Jun; 16(6):435-8. PubMed ID: 1868658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scintigraphic aspects of the recurrence of treated Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Frijlink WB
    J Nucl Med; 1981 Jun; 22(6):510-7. PubMed ID: 7229723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diphosphonate treatment of Paget's disease.
    Finerman GA; Gonick HC; Smith RK; Mayfield JM
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K; Merry P; Scott DG
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone scan appearance of a Paget's osteosarcoma: failure to concentrate HEDP.
    McKillop JH; Fogelman I; Boyle IT; Greig WR
    J Nucl Med; 1977 Oct; 18(10):1039-40. PubMed ID: 409747
    [No Abstract]   [Full Text] [Related]  

  • 53. [Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
    Morales Piga A; García Vadillo A; Rodríguez García A; Elena Ibáñez A; Castro Beiras JM; Rodríguez Torrás M
    Rev Clin Esp; 1985 Oct; 177(6):273-7. PubMed ID: 3936134
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate.
    Anderson DC; O'Driscoll JB; Buckler HM; Cantrill J; Brown JD
    Br J Radiol; 1988 Nov; 61(731):996-1001. PubMed ID: 3208019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapy of Paget's disease of bone].
    Ziegler R; Frank K
    Dtsch Med Wochenschr; 1988 Jan; 113(3):102-5. PubMed ID: 3123193
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of Paget's disease of bone].
    Mimura K
    Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):751-61. PubMed ID: 3936894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The "black beard" sign of monostotic Paget's disease of the mandible.
    Mailander JC
    Clin Nucl Med; 1986 May; 11(5):325-7. PubMed ID: 3698429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.